Ciprofloxacin 250mg tablets

国: イギリス

言語: 英語

ソース: MHRA (Medicines & Healthcare Products Regulatory Agency)

有効成分:

Ciprofloxacin hydrochloride

から入手可能:

Waymade Healthcare Plc

ATCコード:

J01MA02

INN（国際名）:

Ciprofloxacin hydrochloride

投薬量:

250mg

医薬品形態:

Oral tablet

投与経路:

Oral

クラス:

No Controlled Drug Status

処方タイプ:

Valid as a prescribable product

製品概要:

BNF: 05011200

情報リーフレット

PACKAGE LEAFLET:
INFORMATION FOR THE USER
CIPROFLOXACIN 250 MG,
500 MG AND 750 MG TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING
THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION
FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have further questions, please ask your doctor or
your pharmacist.
•
This medicine has been prescribed for you only. Do not
pass it on to others. It may harm them, even if their signs
of illness are the same as yours.
•
If you get any side effects, talk to your doctor, pharmacist
or nurse. This includes any possible side effects not listed
in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Ciprofloxacin is and what is it used for
2. What you need to know before you take Ciprofloxacin
Tablets
3. How to take Ciprofloxacin Tablets
4. Possible side effects
5. How to store Ciprofloxacin Tablets
6. Contents of the pack and other information
The name of this medicine is Ciprofloxacin 250 mg, 500 mg
or 750 mg Film-coated Tablets.
1. WHAT CIPROFLOXACIN IS AND WHAT IS IT USED FOR?
Ciprofloxacin
belongs
to
a
group
of
antibiotics
called
fluoroquinolones. It works by killing some types of bacteria
that can cause infections.
Ciprofloxacin is used to treat bacterial infections including:
•
Lung infections such as pneumonia
•
Infections of the bladder and kidneys
•
Severe gastro-enteritis
•
Infections in the abdomen around the gut
•
Infections of the gall bladder and bile
•
Infections of the skin and spreading infections under the
skin
•
Infections in the womb and tubes leading to the ovaries
and in the area around these organs
•
Infections of the genital organs, including gonorrhoea
(a sexually transmitted disease) and inflammation of the
prostate gland in men
•
Infections in the bones and joints
•
Infections that have spread to the blood
•
Infections in people who have poor immunity to infections
•
Prevention of infections after surgery on the gut or after
procedures that involve passing cameras (endoscopes) int

製品の特徴

1
SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ciprofloxacin 250 mg, film coated tablets.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each
tablet
contains
291.0mg
ciprofloxacin
hydrochloride
equivalent
to
250mg
ciprofloxacin (INN).
For excipients see 6.1
3
PHARMACEUTICAL FORM
Film coated tablets.
Off-white, round, biconvex, film coated tablets with CP/250 on one
side and
on the
other.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Ciprofloxacin is indicated for the treatment of the following
infections caused by
sensitive bacteria:
_ _
_ADULTS:_
_ _
_Respiratory tract infections_: e.g. lobar and bronchopneumonia, acute
and chronic
bronchitis,
acute
exacerbation
of
cystic
fibrosis,
bronchiectasis,
empyema.
Ciprofloxacin
is
not
recommended
as
first-line
therapy
for
the
treatment
of
pneumococcal pneumonia. Ciprofloxacin may be used for treating
Gram-negative
pneumonia.
_ _
_Ear, nose and throat infections_: e.g. mastoiditis, otitis media and
sinusitis, especially
if due to Gram-negative bacteria (including_ Pseudomonas _spp.)_._
Ciprofloxacin is not
recommended for the treatment of acute tonsillitis.
_ _
_Eye infections:_ e.g. bacterial conjunctivitis.
_ _
2
_Urinary _
_tract _
_infections: _
e.g.
uncomplicated
and
complicated
urethritis,
cystitis,
pyelonephritis, prostatitis, epididymitis.
_ _
_Skin and soft tissue infections_: e.g. infected ulcers, wound
infections, abscesses,
cellulitis, otitis externa, erysipelas, infected burns.
_ _
_Bone and joint infections_: e.g. osteomyelitis, septic arthritis.
_ _
_Intra-abdominal infections_: e.g. peritonitis, intra-abdominal
abscesses.
_ _
_Infections of the biliary tract_: e.g. cholangitis, cholecystitis,
empyema of the gall
bladder.
_ _
_Gastro-intestinal infections_: e.g. enteric fever, infective
diarrhoea.
_ _
_Pelvic infections_: e.g. salpingitis, endometritis, pelvic
inflammatory disease.
_ _
_Severe systemic infections_: e.g. septicaemia, bacteraemia,
peritonitis, infections in
immuno-suppressed patients.
_ _
_Gonorrhoea_:
including
urethr